U.S. Adults Spent More on Lipitor in 2004 than Any Other Drug

• Drug News • • Public Health • Sep 24, 2007



	Tweet

With a total nearly $5 billion, Lipitor, a cholesterol-reducing drug, ranked first in terms of total spending on prescription medicines by adults ages 18 to 64 in 2004, and another cholesterol-fighting drug, Zocor, ranked fourth at $2.3 billion, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.

Rounding out the top five prescribed drugs for adults were second- and third-ranked Nexium ($2.7 billion) and Prevacid ($2.4 billion) – proton-pump inhibitor drugs that reduce stomach acid—and Zoloft, an antidepressant ($1.9 billion), which ranked fifth.

AHRQ data also found that:

For people age 65 and older, Lipitor and Zocor ranked first and second in total spending ($4.35 billion and $2.4 billion, respectively), followed by Plavix, an antiplatlet drug ($1.7 billion), Norvasc, a calcium channel blocker that can be used to treat High Blood Pressure and certain kinds of chest pain, such as angina ($1.5 billion), and Nexium ($1.5 billion).

For children age 17 and under, the top five drugs when ranked by total expenses were Singulair ($680 million), a medication that can be used to control asthma, ranked first; Concerta ($490 million), Strattera ($430 million), and Adderall ($410 million), drugs commonly used to treat attention-deficit hyperactivity disorder, ranked second, third and fifth, respectively; and Zyrtec, an antihistamine ($420 million), ranked fourth.

AHRQ, which is part of the U.S. Department of Health and Human Services, works to enhance the quality, safety, efficiency, and effectiveness of health care in the United States. The data in this AHRQ News and Numbers summary are taken from the Medical Expenditure Panel Survey (MEPS), a highly detailed source of information on the health services used by Americans, the frequency with which they use them, the cost of those services, and how they are paid. More information is available in The Top Five Outpatient Prescription Drugs Ranked by the Expense for Children, Adults, and the Elderly, 2004

Source: Agency for Healthcare Research and Quality (AHRQ)

Provided by ArmMed Media



RELATED STORIES:
“Naked Chef” puts junk food high on UK election menu Parents win high court battle to keep their baby alive Complications Are Not Best Predictor of Hospital Mortality Vitamin E High doses may increase risk of death Leukemia Drug Gleevec Continues to Amaze U.S. worried by health disparities among Hispanics Traditional media and internet more trusted than social media for research news Thai doctors acquitted on murder-for-organ charges Anthrax tests at Pentagon prove negative Fewer deaths than initially projected for the second half of 2003, helped by more seat belt use, pus One in 7 households hit by hunger issues in 2009 No Law Broken In Rx Cost Row

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]

Exercise in early 20s may lower risk of osteoporosis
- Full Story - - »»»

Games and Interactive Media Are Powerful Tools for Health Promotion and Childhood Obesity Prevention
- Full Story - - »»»

Primary care program helps obese teen girls manage weight, improve body image and behavior
- Full Story - - »»»

Optimism about heart risks may be a good thing
- Full Story - - »»»

Study shows fainting factor in cardiac arrests
- Full Story - - »»»

Teen pregnancy, abortion rates at record low, study says
- Full Story - - »»»

Think you can’t get pregnant? Try again, study says
- Full Story - - »»»